Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

RAK · NZX

Rakon (RAK)

Technology / Electronics•Covered: FY22 - HY26•7 published briefings

Rakon is an NZX-listed technology / electronics company with FY22 - HY26 of published result briefings.

Latest briefing

HY26 · Released 28 November 2025

Revenue up 30.2% but Rakon stays loss-making with trade debtors surging 52.9%

Strong demand recovery lifted Underlying EBITDA 149% and narrowed the PBT loss by 73.6%, but a NZ$18.8m receivables build means cash is not yet

Market data

As at close

Public display suppressed because the price is not confirmed as an end-of-day close.

Sections⌄
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights

Snapshot

Latest metrics

HY26, released 28 November 2025

← Swipe to view more
RAK latest metrics
MetricValueChange
Revenue$54.2m↑ +30.2%
EBITDA$3.6m↑ +122.8%
NPAT-$3m↑ +71.2%
Operating cash flow$6.4m↓ -23.7%
OCF / EBITDA %176.7%↑ +229.5pp
Net debt-$0.85m↑ +91.7%
Net debt / EBITDA-0.23x↓ -135.4%
ROE %-1.9%↑ +5.1pp
PBT-$4m↑ +73.5%
FCF pre-lease-$1.5m↓ -207.1%

Source: latest published briefing (HY26, released 28 November 2025). Change compares against the prior equivalent period: HY25, released 27 November 2024.

Valuation

Valuation

A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.

Price and market cap

The latest close and share count context for the market price.

Market cap

Not available

i

Not available for this company right now.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not available for this company right now.

P/B

Not available

i

Not available for this company right now.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

Not available

i

Not available for this company right now.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Chat

Ask about RAK

Ask follow-up questions about Rakon's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about RAK

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
RAK metric history
MetricHY266 MONTHS28 November 2025HY256 MONTHS27 November 2024FY2412 MONTHS29 May 2024HY246 MONTHS23 November 2023FY2312 MONTHS24 May 2023HY236 MONTHS24 November 2022FY2212 MONTHS26 May 2022Trend
Revenue$54.2m$41.7m$128m$61.3m$180.3m$87.2m$172m
Chart
Revenue growth %30.2%Outside range highOutside range high revenue growth. 30.2%; 3-period range -32% to 2%. Revenue growth: 30.2%, above normal range; 3-period mean -19.9%, range -32.0%-2.0%.-32.0%Outside range lowOutside range low revenue growth. -32%; 3-period range -29.7% to 30.2%. Revenue growth: -32.0%, below normal range; 3-period mean 0.8%, range -29.7%-30.2%.-29.0%-29.7%4.9%2.0%34.1%
Chart
  • HY25 Revenue growth %: Outside range low revenue growth. -32%; 3-period range -29.7% to 30.2%. Revenue growth: -32.0%, below normal range; 3-period mean 0.8%, range -29.7%-30.2%.
  • HY26 Revenue growth %: Outside range high revenue growth. 30.2%; 3-period range -32% to 2%. Revenue growth: 30.2%, above normal range; 3-period mean -19.9%, range -32.0%-2.0%.
EBITDA$3.6m-$15.8m$13.5m$5.3m$42.2m$22.9m$41.4m
Chart
EBITDA margin %6.6%-37.9%10.5%8.6%23.4%26.2%24.1%
Chart
PBT-$4m-$15.1m$0.3m$0.2m$31.4m$22.4m$41.9m
Chart
PBT growth %——-99.0%-99.1%-25.1%14.9%274.1%
Chart
NPAT-$3m-$10.4m$4.5m$0.5m$23.2m$16m$33.1m
Chart
NPAT growth %——-80.6%-96.9%-29.9%-15.3%244.8%
Chart
Operating cash flow$6.4m$8.3m$17.8m$7.3m$11.1m$0.02m$30.2m
Chart
OCF / EBITDA %176.7%-52.8%132.1%139.1%26.3%0.1%73.0%
Chart
FCF pre-lease-$1.5m$1.4m$0.8m$1.2m-$7.6m-$9.4m$20.1m
Chart
FCF post-lease-$1.5m——————
—
DPS————1.5c—0.0c
Chart
Payout ratio vs NPAT %————14.7%——
—
Annual payout ratio vs EPS %————14.7%——
—
ROE %-1.9%-7.0%Outside range lowOutside range low roe. -7%; 3-period range -1.9% to 12.3%. ROE: -7.0%, below normal range; 3-period mean 3.6%, range -1.9%-12.3%.2.8%0.3%14.8%12.3%Outside range highOutside range high roe. 12.3%; 3-period range -7% to 0.3%. ROE: 12.3%, above normal range; 3-period mean -2.9%, range -7.0%-0.3%.24.5%
Chart
  • HY25 ROE %: Outside range low roe. -7%; 3-period range -1.9% to 12.3%. ROE: -7.0%, below normal range; 3-period mean 3.6%, range -1.9%-12.3%.
Net debt-$0.85m-$10.2m-$11.2m-$13.4m-$16.5m-$18.4m-$23.2m
Chart
Net debt / EBITDA-0.23x0.65x-0.83x-2.55x-0.39x-0.8x-0.56x
Chart
Debtor days1831559713685—70
Chart
Inventory days190225157178127302122
Chart
Total assets$230.9m$193.9m$207.1m$197.5m$207.3m$218.4m$199.9m
Chart

Reference: annolyse.ai/companies/rak

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

↗
Loading chart...

Revenue growth

Like-period revenue growth where comparable.

↗
Loading chart...
  • HY25 RAK HY: Outside range low revenue growth. -32%; 3-period range -29.7% to 30.2%. Revenue growth: -32.0%, below normal range; 3-period mean 0.8%, range -29.7%-30.2%.
  • HY26 RAK HY: Outside range high revenue growth. 30.2%; 3-period range -32% to 2%. Revenue growth: 30.2%, above normal range; 3-period mean -19.9%, range -32.0%-2.0%.

EBITDA-equivalent

Company-specific earnings measure where disclosed.

↗
Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

↗
Loading chart...

NPAT

Statutory profit after tax.

↗
Loading chart...

Operating cash flow

Cash generated from operations.

↗
Loading chart...

Full chartable metric set

Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.

OCF / EBITDA

Cash conversion against earnings.

↗
Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

↗
Loading chart...

FCF post-lease

Free cash flow after lease payments where available.

↗
Loading chart...

ROE

Return on equity.

↗
Loading chart...
  • HY23 RAK HY: Outside range high roe. 12.3%; 3-period range -7% to 0.3%. ROE: 12.3%, above normal range; 3-period mean -2.9%, range -7.0%-0.3%.
  • HY25 RAK HY: Outside range low roe. -7%; 3-period range -1.9% to 12.3%. ROE: -7.0%, below normal range; 3-period mean 3.6%, range -1.9%-12.3%.

Net debt

Borrowings less cash; negative values indicate net cash.

↗
Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

↗
Loading chart...

DPS

Dividend per share declared for the period.

↗
Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

↗
Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

↗
Loading chart...

Inventory days

Inventory days where the working-capital inputs are source-backed.

↗
Loading chart...

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...
  • HY24 RAK: Outside range high operating working-capital movement. $33.8m; 3-period range $-18.7m to $28.4m. Operating working-capital movement: NZ$33.8m, above normal range; 2/3 prior periods had builds averaging NZ$26.2m, and 1 had releases averaging NZ$-18.7m.
  • HY25 RAK: Outside range low operating working-capital movement. $-18.7m; 3-period range $24m to $33.8m. Operating working-capital movement: NZ$-18.7m, below normal range; 3/3 prior periods had builds averaging NZ$28.7m, and none had a working-capital release.

The setup & the reality

HY25 → HY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

HY26 · Released 28 November 2025

Revenue up 30.2% but Rakon stays loss-making with trade debtors surging 52.9%

Strong demand recovery lifted Underlying EBITDA 149% and narrowed the PBT loss by 73.6%, but a NZ$18.8m receivables build means cash is not yet

Read latest briefing→

Historical setup

What HY25 said to watch

From Revenue fell 32% pushing Rakon to a $15.1m PBT loss

No quantified guidance, revenue target, or forward-work figure is supplied. Management commentary points to "robust demand in Space and AI & Cloud Infrastructure" underpinning future growth, but does not quantify the second-half path. Historically the business is second-half-weighted: HY24 was 47.9% of FY24 revenue and only 11.1% of FY24 NPAT.

Annualising the current half implies an $83.3m revenue run-rate against FY24's $128.0m, so even a normal second-half skew leaves a wide gap to last year. The release does not contain enough forward information to judge whether HY25 is the trough or the new base.

Open questions

Open questions from HY25

  • Is the demand weakness in Telecommunications and Global Positioning expected to reverse in the second half, or does management view the current run-rate as the new base?
  • How much of the $18.7m working-capital release is repeatable, and what steady-state inventory level supports the Space and AI & Cloud Infrastructure pipeline?
  • Why have inventory days lengthened 47 days despite the absolute reduction, and which products or customers are driving that?
  • What forward order book or contracted revenue underpins the second-half recovery implied by the FY24 seasonal shape?
  • Will capex stay near 16.6% of revenue, and at what point does it step down as strategic programmes mature?

This briefing cannot assess segment profitability or gross-margin trajectory because the disclosure does not break out result by segment or provide a like-for-like gross-margin reconciliation.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

HY26 · Released 28 November 2025

Revenue up 30.2% but Rakon stays loss-making with trade debtors surging 52.9%

Strong demand recovery lifted Underlying EBITDA 149% and narrowed the PBT loss by 73.6%, but a NZ$18.8m receivables build means cash is not yet

Read briefing→

HY25 · Released 27 November 2024

Revenue fell 32% pushing Rakon to a $15.1m PBT loss

Operating cash flow rose 14% but only via $18.7m of working-capital release; inventory days still climbed 47 days.

Read briefing→

FY24 · Released 29 May 2024

PBT collapsed 99% on a 29% revenue fall as a tax credit propped up NPAT

Operating cash flow rose 60.5% but on working-capital release, while a tax benefit lifted NPAT to $4.5m well above near-zero PBT.

Read briefing→

HY24 · Released 23 November 2023

Revenue fell 29.7%, EBITDA collapsed 81.3% on operating deleverage

Cash flow swung positive on an inventory unwind, but PBT was effectively wiped out and ROE fell from 11.5% to 0.3%.

Read briefing→

FY23 · Released 24 May 2023

Revenue grew 4.9% but operating cash flow collapsed 63% and FCF turned negative

Capex more than doubled and working capital absorbed $15.0m, turning a $21.8m FCF inflow into a $7.6m outflow while NPAT fell 29.9%.

Read briefing→

HY23 · Released 24 November 2022

Inventory build of $28.5m wiped operating cash flow despite PBT up 14.9%

PBT grew 14.9% on 2.0% revenue growth, but a $28.5m inventory build cut operating cash flow from $4.5m to $0.0m and turned free cash flow negative.

Read briefing→

FY22 · Released 26 May 2022

NPAT up 244.8% but cash conversion fell to 55.6% on inventory build

Record earnings were undercut by a $19.6m inventory build and capex more than doubling, cutting FCF/NPAT conversion from 164.5% to 60.6%.

Read briefing→

Related insights

Compare this company

The latest RAK metrics also appear in these cross-company views.

Insight

Cash conversion quality

This result converted 176.7% of EBITDA to operating cash flow.

Open insight→

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 2.1pp, with a distortion flag in the result.

Open insight→

Insight

Revenue growth context

Revenue growth was 30.2% for this reporting period.

Open insight→

Insight

Dividend coverage and payout pressure

Dividend payout versus NPAT is 0.0%.

Open insight→

Get notified when RAK publishes

Get the next Rakon result briefing and five-year history updates by email.